Kathleen Shannon, MD
Neurology · Madison, WINPI 1396721767
Payments from drug & device makers
What this record shows
Sage Therapeutics, LLC accounts for 91.7% of it on its own, with 2 other manufacturers making up the rest.
Across 11 payments — averaging $86.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$874
- Lundbeck LLC$65
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15
Across 11 payments — averaging $10,605 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sage Therapeutics, LLC$77K
- Eli Lilly$40K
What the payments were for
- Travel & lodging$52955%
- Food & beverage$42445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 9 | $874 |
| Lundbeck LLC | 1 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$953 in reported general payments places this provider in the 70th percentile of 308 neurology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 61 | $449,829 |
| AustedoDeutetrabenazine | 29 | $248,733 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 789 | $38,947 |
| RytaryCarbidopa/Levodopa | 15 | $19,928 |
| Selegiline Hcl | 79 | $8,705 |
| AmantadineAmantadine Hcl | 168 | $7,506 |
| Primidone | 140 | $6,541 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 111 | $5,129 |
| Rasagiline Mesylate | 22 | $3,109 |
| Pyridostigmine Bromide | 16 | $3,065 |
| Donepezil Hcl | 237 | $2,986 |
| Gabapentin | 136 | $2,751 |
| Rivastigmine | 12 | $2,233 |
| Risperidone | 154 | $1,843 |
| Dalfampridine ErDalfampridine | 11 | $1,073 |
Paid to pharmacies, not to this prescriber.
Other neurology in Madison
- Michael SnyderMadison$284K
- Kelsey GageschMadison$60K
- Brian NagleMadison$25K
- Michael FruchtMadison$22K
- Vanesa BotsfordMadison$11K
- Amanda AbuafMadison$11K
- Christopher LuzzioMadison$9K
- Ankush BhatiaMadison$7K
- Rama MagantiMadison$6K
- Elizabeth FeltonMadison$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.